The Canadian E-PAraDiGM (Exercise Physical Activity and Diabetes Glucose Monitoring) Protocol
- Conditions
- Seated ControlWalking
- Interventions
- Behavioral: Seated ControlBehavioral: Walking
- Registration Number
- NCT02834689
- Lead Sponsor
- University of British Columbia
- Brief Summary
Walking is encouraged for people with type 2 diabetes but there is little evidence that performing a bout of walking can improve glucose control. Furthermore, it is unknown how participant characteristics (e.g., age, sex, medications) impact the acute glucose responses to walking in people with type 2 diabetes. The primary purpose of this study is to examine how a standardized bout of walking impacts glucose control assessed over 24 hours using continuous glucose monitoring. A secondary purpose is to determine whether responses are influenced by age, sex, and medication use.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 79
- Diagnosed with T2D for more than 6 months
- 30-90 years of age
- No contra-indications to exercise (PAR-Q+, Rose Angina questionnaire, limited ability to walk for 50 min).
- No previous myocardial infarction, stroke or diagnosed coronary artery disease
- No changes in diabetes medication in last 3 months
- Not treated by insulin or corticosteroids
- No significant change in body weight (>5%) in last 3 months
- Blood pressure <160/100 mmHg; resting HR<100
- Able to understand English or French and comply with study requirements (e.g., attend visits during the day)
- Hemoglobin A1C <9.0%
- No prior history of hypoglycaemia during activity or sleep
- Chest pain during physical activity.
- Chest pain while resting (no physical activity) in the past month.
- Loss of balance or consciousness because of dizziness in past 12 months
- Bone or joint problem (for example, back, knee, or hip) that could be made worse by a change in physical activity.
- Currently pregnant or planning on becoming pregnant in the next 3 months
- Currently taking exogenous insulin
- Previous heart attack or stroke
- Any other reason that prevents ability to walk on a treadmill for 50 minutes
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Seated Control Seated Control Sitting for 50 minutes Walking Walking Walking on a treadmill at 3.5 metabolic equivalents (METS) for 50 minutes
- Primary Outcome Measures
Name Time Method Mean 24 hour glucose levels (mmol/l) 24 hours Mean glucose assessed for 24 hours after walking or seated control assessed by continuous glucose monitoring
- Secondary Outcome Measures
Name Time Method Mean amplitude of glycemic excursions (MAGE) 24 hours MAGE assessed for 24 hours after walking or seated control assessed by continuous glucose monitoring
Standard Deviation of Glucose Values 24 hours Standard deviation of glucose values assessed for 24 hours after walking or seated control assessed by continuous glucose monitoring
Post-dinner glucose control 2 hours following dinner Incremental area under the glucose curve for 2 hours following dinner
Post-lunch glucose control 2 hours following lunch Incremental area under the glucose curve for 2 hours following lunch
Post-breakfast glucose control 2 hour following breakfast Incremental area under the glucose curve for 2 hours following breakfast
Time spent above 10 mmol/l glucose 24 hours following walking or seated control Time in minutes above 10 mmol/l assessed by continuous glucose monitoring over 24 hours
Trial Locations
- Locations (1)
University of British Columbia, Okanagan.
🇨🇦Kelowna, British Columbia, Canada